10-99845936-A-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000392.5(ABCC2):​c.4146+154A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.152 in 152,192 control chromosomes in the GnomAD database, including 2,029 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.15 ( 2029 hom., cov: 32)

Consequence

ABCC2
NM_000392.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.675

Publications

53 publications found
Variant links:
Genes affected
ABCC2 (HGNC:53): (ATP binding cassette subfamily C member 2) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008]
ABCC2 Gene-Disease associations (from GenCC):
  • Dubin-Johnson syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 10-99845936-A-G is Benign according to our data. Variant chr10-99845936-A-G is described in ClinVar as Benign. ClinVar VariationId is 1181401.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000392.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCC2
NM_000392.5
MANE Select
c.4146+154A>G
intron
N/ANP_000383.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ABCC2
ENST00000647814.1
MANE Select
c.4146+154A>G
intron
N/AENSP00000497274.1
ABCC2
ENST00000648523.1
n.33+154A>G
intron
N/AENSP00000497778.1
ABCC2
ENST00000649459.1
n.494+154A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
23022
AN:
152074
Hom.:
2007
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.215
Gnomad AMI
AF:
0.0537
Gnomad AMR
AF:
0.135
Gnomad ASJ
AF:
0.177
Gnomad EAS
AF:
0.332
Gnomad SAS
AF:
0.220
Gnomad FIN
AF:
0.101
Gnomad MID
AF:
0.237
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.144
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.152
AC:
23089
AN:
152192
Hom.:
2029
Cov.:
32
AF XY:
0.154
AC XY:
11455
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.215
AC:
8940
AN:
41518
American (AMR)
AF:
0.135
AC:
2060
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.177
AC:
613
AN:
3470
East Asian (EAS)
AF:
0.333
AC:
1725
AN:
5180
South Asian (SAS)
AF:
0.221
AC:
1065
AN:
4814
European-Finnish (FIN)
AF:
0.101
AC:
1069
AN:
10592
Middle Eastern (MID)
AF:
0.231
AC:
68
AN:
294
European-Non Finnish (NFE)
AF:
0.106
AC:
7183
AN:
68018
Other (OTH)
AF:
0.150
AC:
317
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
989
1977
2966
3954
4943
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
264
528
792
1056
1320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.124
Hom.:
6024
Bravo
AF:
0.159
Asia WGS
AF:
0.297
AC:
1029
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
2.1
DANN
Benign
0.60
PhyloP100
-0.68
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3740065; hg19: chr10-101605693; API